| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/25/2007 | CA2112701C Proteins s polypeptides and uses thereof |
| 09/20/2007 | WO2007104489A1 Method for the preparation of a composition based on 4-hydroxyproline and the uses thereof in the agronomical field |
| 09/20/2007 | WO2007056114B1 Compositions and methods for the detection of trypanosoma cruzi infection |
| 09/20/2007 | WO2007047301A3 Selective posttranslational modification of phage-displayed polypeptides |
| 09/20/2007 | WO2007027178A3 Lyophilized platelet rich plasma for the use in wound healing and bone or tissue grafts or repair |
| 09/20/2007 | WO2007024997A3 Methods of increasing production of secondary metabolites |
| 09/20/2007 | US20070220620 TAT-046 and methods of assessing and treating cancer |
| 09/20/2007 | US20070219355 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 09/20/2007 | US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219269 Novel aconitase |
| 09/20/2007 | US20070219132 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 09/20/2007 | US20070219128 Medical and health-care uses of pufferfish type I collagen extract and processes for producing said extract |
| 09/20/2007 | US20070218528 Methods and compositions for targeted cleavage and recombination |
| 09/20/2007 | US20070218527 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/20/2007 | US20070218525 Process for Producing Dipeptides |
| 09/20/2007 | US20070218524 Polypeptide Having Rnase III Activity |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218516 Recombinant chimeric human anti-botulinum antibodies |
| 09/20/2007 | US20070218507 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 09/20/2007 | US20070218470 Method for selective inactivation of viral replication |
| 09/20/2007 | US20070218466 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA |
| 09/20/2007 | US20070218463 Rearranged squamous cell carcinoma antigen genes II |
| 09/20/2007 | US20070218075 immunogens; glutamine based point mutations |
| 09/20/2007 | US20070218071 Novel therapeutic targets in cancer |
| 09/20/2007 | US20070218069 antibodies that specifically binds ubiquitin comprising a lysine linkage between a lysine residue of one ubiquitin molecule and the C-terminal glycine residue of another ubiquitin molecule |
| 09/20/2007 | US20070218067 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors |
| 09/20/2007 | US20070218066 For clinical screening, diagnosis, prognosis, therapy and prophylaxis of conditions involving the pathology of epithelial cells and particularly those of the alimentary canal |
| 09/20/2007 | US20070218064 Human anti-il-23 antibodies, compositions, methods and uses |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218055 Ferroportin1 nucleic acids and proteins |
| 09/20/2007 | US20070218054 In Vitro germinal centers |
| 09/20/2007 | US20070218053 Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | US20070215475 Factor VIII separation |
| 09/20/2007 | CA2647150A1 Plant seed oils containing polyunsaturated fatty acids |
| 09/20/2007 | CA2645148A1 Soybean seed and oil compositions and methods of making same |
| 09/19/2007 | EP1835029A1 Papillomavirus vaccines |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834671A2 A method for generation of antibodies to cell surface molecules |
| 09/19/2007 | EP1834645A1 Autoinducer synthase modulating compounds and uses therefor |
| 09/19/2007 | EP1833979A2 Nucleic acid molecules for optimized cab-2 expression and their use |
| 09/19/2007 | EP1833978A1 Tripeptide and tetrapeptide thioethers |
| 09/19/2007 | EP1833846A2 Method for production of a therapeutically pure granulocyte macrophage - colony stimulating factor |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1833842A1 Tripeptide and tetrapeptide sulfones |
| 09/19/2007 | EP1563073A4 Protein production methods and modified cells for use therein |
| 09/19/2007 | EP1407054B1 Expression system |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1151304B1 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 09/19/2007 | EP1142995B1 Antiuracil monoclonal antibody |
| 09/19/2007 | EP1141003B1 Methods of activation of SGK by phosphorylation. |
| 09/19/2007 | EP1020522B1 Natural human antibody |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101037692A Method for expressing human insulin by using plant seed oil body |
| 09/19/2007 | CN101037476A Fusion protein for preparing hepatitis B vaccine and its carrier |
| 09/19/2007 | CN101037468A Preparation method of oyster active peptides |
| 09/19/2007 | CN100338224C Method for preparing peptide of soybean through continuous enzyme membrane reaction of soyabean protein |
| 09/18/2007 | US7271252 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 09/18/2007 | US7271251 Polyclonal and, or monoclonal antibodies; immuniglobulin immunization |
| 09/18/2007 | US7271250 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 09/18/2007 | US7271249 Biosensors, method for obtaining the same and uses thereof |
| 09/18/2007 | US7271247 Antibody that binds to the protein; given amino acid sequence |
| 09/18/2007 | US7271243 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics |
| 09/18/2007 | US7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271149 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 09/18/2007 | US7271147 Tripropeptin antibiotic |
| 09/18/2007 | US7271000 Providing cells containing double-stranded DNA, wherein such DNA comprising atleast I-Sce I meganucleases and selecting the cells in which double strand break has been induced; useful for mapping eukaryotic genomes; genetic engineering |
| 09/18/2007 | US7270999 Clock gene BMAL2 |
| 09/18/2007 | US7270993 Transgenic cell comprising paracrystalline protein surface layer cleaving proteins for use as bioreactor: heterologous protein expression |
| 09/18/2007 | US7270991 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development |
| 09/18/2007 | US7270990 Virus production |
| 09/18/2007 | US7270985 Process for the preparation of aldehyde from a proteinous source for industrial applications |
| 09/18/2007 | US7270979 DNA for expression of alpha 1-antitrypsin in methylotropic yeast |
| 09/18/2007 | US7270967 Nucleotide sequences coding preferential polypetpide for use in diagnosis and treatment of preferential genetic disorders |
| 09/18/2007 | US7270966 for drug screening agents for treatment and/or prevention of cystic fibrosis by receptor binding ligand; genetic engineering |
| 09/18/2007 | US7270960 Diagnosis of ovarian carcinomas |
| 09/18/2007 | US7270950 Nucleic acid-protein fusions and methods of making and selecting fusions |
| 09/18/2007 | US7270827 For prophylaxis and therapy of microbial infection and eliciting a protective immune response |
| 09/18/2007 | US7270825 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 09/18/2007 | US7270821 Hepatitis B core antigen fusion proteins |
| 09/18/2007 | US7270809 cysteine-added granulocyte colony-stimulating factor; prolongs circulating half-lives of protein therapeutics so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via cysteine |
| 09/18/2007 | US7270807 subtilisin, pepsin or trypsin used for the protein hydrolysis of ground oyster flesh; liquid form; freeze dried powder form |
| 09/18/2007 | CA2426543C Anti-angiogenic polypeptides |
| 09/18/2007 | CA2404248C Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2007 | CA2102043C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 09/13/2007 | WO2007103146A2 Truncated proteins as cancer markers |
| 09/13/2007 | WO2007102936A2 Polynucleotides for production of farnesyl dibenzodiazepinones |
| 09/13/2007 | WO2007102442A1 Monoclonal antibody, hybridoma, and method for quantification of lipopolysaccharide |
| 09/13/2007 | WO2007102432A1 Method for producing glycoprotein composition |
| 09/13/2007 | WO2007102230A1 Humanized anti-cd20 monoclonal antibody |
| 09/13/2007 | WO2007102229A1 Guadinomine substance and method for producing the same |
| 09/13/2007 | WO2007102200A1 Anti-cd20 monoclonal antibody |
| 09/13/2007 | WO2007002532A3 Cell lines for expressing enzyme useful in the preparation of amidated products |
| 09/13/2007 | WO2006101584A3 Cellulases, nucleic acids encoding them and methods for making and using them |
| 09/13/2007 | WO2006096989A3 Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the gly-gly-ala domain for enhanced transient gene expression |
| 09/13/2007 | WO2005062780A3 In vivo odorant receptor systems and their uses |